CTs Detect Frailty, Predict Survival
Findings from a new study conducted by radiologists at UC Davis and Wake Forest Bapist medical centres suggest that using computed tomography (CT) to evaluate muscle health may help identify optimal treatments for older patients who fall and break their hips. The study is published in the American Journal of Roentgenology.
This is the first study that links the use of imaging technology with survival after hip fractures. The study was condcuted with 300 participants at least 65 years of age and treated for fall-related injuries. All participants were suspected of breaking their hips. Patients received CTs to diagnose or rule out fracture. CTs were evaluated with additional measurements of size and density of the lumbar and thoracic muscle. Information was then compared with mortality data from the National Death Index.
Research findings showed that decreased core muscle that stabilises the spine was associated with decreased survival times after hip fractures. Patients with better core muscle had better survival rates.
Hip fractures are one of the most common causes of injury, hospitalisation and disability among older Americans. By using CT and by gathering information about muscle loss, doctors can determine the frailty level of a patient. This can in turn guide treatment decisions. If CTs show frailty in a patient, that patient would benefit more from a simpler surgery as compared to a patient with favourable life expectancy who could be treated with total hip arthroplasty.
As lead author Robert Boutin explains, the use of CT scans to evaluate muscles and hip bones can better help predict longevity and this in turn can help personalise treatment as per the patient's needs.
The researchers are hopeful that their findings will inspire additional studies in this area and would expand research that is focused on improving orthopaedic treatments for older patients.
Source: University of California - Davis Health System
Image Credit: Copyright UC Regents 2017
Published on : Tue, 6 Jun 2017
A breakthrough in biopsy efficiency The Brevera system streamlines the entire breast biopsy process from start to finish – with real-time imaging for instant verification and automated post-biopsy specimen handling. This has the potential to...
BioZorb® 3D Bioabsorbable Marker The BioZorb® is a 3D implantable marker that consists of a spiral, bioabsorbable framework embedded with 6 permanent, titanium clips designed to precisely mark your surgical excision site. Designed to improve outcomes...
Introducing a new chapter in ultrasound visualization technology. X-Porte was developed from the ground up to incorporate a breakthrough, proprietary beam-forming technology: XDI (Extreme Definition Imaging). This signal analysis algorithm shapes...
We recognize that the best chance any patient has at getting better is a clinician at their bedside with all the right answers and the confidence to act. SonoSite education and training is the industry standard – no other point-of-care ultrasound manufacturer...